🟢 Quantum BioPharma is trading 7% up in pre-market amid broader biotech-sector buying

Quantum BioPharma is trading at $2.60, up 7.00% in pre-market, with biotech-sector strength the more likely context.

• The XBI gained 3.64% on October 20 amid broad sector buying; Quantum BioPharma’s prior session closed at $2.43.
• No confirmed fresh company-specific catalyst was identified for the October 21 pre-market move. Thermo Fisher Phase 2 trial news found in search appears to be earlier coverage, not a new announcement; no verified company-specific event directly explains the move.